A2A adenosine receptor protects tumors from antitumor T cells. - Wikidata - wikimedia - TriplyDB

A2A adenosine receptor protects tumors from antitumor T cells.

A2A adenosine receptor protects tumors from antitumor T cells.

http://www.wikidata.org/entity/Q35016529

about

Purinergic signalling and cancer Adenosine receptors and asthma in humans A Metabolic Immune Checkpoint: Adenosine in Tumor Microenvironment Relevance of tumor-infiltrating lymphocytes in breast cancer CD73 and CD39 ectonucleotidases in T cell differentiation: Beyond immunosuppression CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth Ways to enhance lymphocyte trafficking into tumors and fitness of tumor infiltrating lymphocytes Primer on tumor immunology and cancer immunotherapy Immune modulation of the tumor microenvironment for enhancing cancer immunotherapy Ectonucleotidases in tumor cells and tumor-associated immune cells: an overview The role and regulation of human Th17 cells in tumor immunity CD73 expression is dynamically regulated in the germinal center and bone marrow plasma cells are diminished in its absence Molecularly and clinically related drugs and diseases are enriched in phenotypically similar drug-disease pairs Myeloid cells in the tumor microenvironment: Role of adenosine Cyclic AMP Represents a Crucial Component of Treg Cell-Mediated Immune Regulation The ever-expanding role of HIF in tumour and stromal biology A2aR antagonists: Next generation checkpoint blockade for cancer immunotherapy Adenosine A2A receptors intrinsically regulate CD8+ T cells in the tumor microenvironment Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase Adenosine receptors in regulation of dendritic cell differentiation and function Context-Specific and Immune Cell-Dependent Antitumor Activities of α1-Antitrypsin Adenosine receptors as drug targets--what are the challenges?Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression.Cancer immunotherapy comes of age The immunosuppressive role of adenosine A2A receptors in ischemia reperfusion injury and islet transplantation.Adenosine A2B receptor blockade slows growth of bladder and breast tumors.Immunological alterations mediated by adenosine during host-microbial interactions Adenosine receptor A2A deficiency in leukocytes increases arterial neointima formation in apolipoprotein E-deficient mice Much ado about adenosine: adenosine synthesis and function in regulatory T cell biology.The role of adenosine A2A receptor signaling in bronchiolitis obliterans.A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells.Adenosine arrests breast cancer cell motility by A3 receptor stimulation.Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival.Cerebral blood flow response in adenosine 2a receptor knockout mice during transient hypoxic hypoxia.CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation.Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis.Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells.A Novel Antagonist of the Immune Checkpoint Protein Adenosine A2a Receptor Restores Tumor-Infiltrating Lymphocyte Activity in the Context of the Tumor Microenvironment.Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma.

P2860

Q24618782-9FEAA9F4-368A-450B-840D-99DDCF9C59F4 Q24644125-756DB309-0995-434F-AB2B-305390FC3485 Q26749571-8792E457-6069-4667-A2E9-40534851A153 Q26795598-0BBF64DD-39B9-45C7-91BE-3897C2782874 Q26801436-FB9DF92E-3368-4229-B752-1FE97556E2A4 Q26823709-48A91D2A-1A1C-458E-BBBA-1AC83DA63C3B Q26991991-D43ECE9C-AC45-4577-B902-09C0FA44D5AC Q27001126-1F6BB06B-C5DA-4842-A918-1D3F99C0F8F1 Q27002646-94A5AF64-2317-46E7-9AD2-A1C3042AEFEC Q27002950-137C0ECE-F049-45CE-A635-4305D744CD1D Q27011396-E3C3B906-95F4-4067-866F-F2E38DB86D4D Q27315065-18B16C3C-004A-4281-B7DF-FE060905E244 Q27499827-D4014F83-710D-4050-BF39-F75EB402E348 Q28069621-B501BA86-B140-4B81-A5A3-6108D29F836D Q28072162-5917BFFA-9803-4E7E-A07D-05D2D463D660 Q28079015-A7B5409F-6493-401C-9787-B86E9457FB44 Q28087576-9C3B7CFF-DBD5-4AAF-8891-C53D51A92C0C Q28250207-7C74E07F-9949-420B-BA3C-67747E5CBD5B Q28473067-2ADB84ED-55F4-4DAF-ABDD-2850EBC8502A Q28586835-4BF15601-2E8B-4EDB-B4BF-591D0B5F5448 Q28817846-D2ACABC4-A9AF-49BC-9F66-EF4BB219F165 Q29346491-80CC8C3F-DDD4-44B8-BEB3-106CA36C9185 Q29615344-FE442A9E-2ADB-448C-B7DD-671448D9DB22 Q29619918-D94FB1B0-4D1C-45BD-B370-B3BC75BED1B3 Q30409961-4D4D8883-4547-4610-89EF-1D491EB9EDE8 Q30416420-C491B549-9D50-460E-9950-6C920C16A6EA Q30426800-9553F402-61B5-4434-8556-66F2A76A17E0 Q30432457-2F02DFEA-1872-4DDF-860F-6D539B3AFDB9 Q30433245-F4434CE5-5C2C-4716-8E77-10EB22FB1F0E Q30437818-55D761FF-112C-4178-B4CD-64FCA48924DF Q30440525-B34F367C-C48C-4F0C-A194-47A37F6148F0 Q30829844-40CF71A1-CC53-41EA-9B8E-CEC93B83BB46 Q33297014-4B1D1965-B8F3-455D-A9E3-0B4A5CC5CD29 Q33342407-1B7F4F32-24AD-410C-812C-449CDE208D48 Q33533705-BE0EE8CE-7C80-4CF8-8306-3F1E8AB16AA0 Q33615249-61048E88-445A-4388-9B4C-87CDCDE96FBB Q33667612-4F1AA9F1-DBC6-4C8F-A1FC-1C86794316B0 Q33748026-C3755481-0736-4B39-B18E-1A7B5AA92E85 Q33763266-52EA8F62-5CAB-41F5-98D0-54AABDA1E029 Q33771631-992EB296-34EE-404D-9B84-5F9F8089DDB8

P2860

A2A adenosine receptor protects tumors from antitumor T cells.

http://www.wikidata.org/entity/Q35016529

description

2006 nî lūn-bûn

@nan

2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

A2A adenosine receptor protects tumors from antitumor T cells.

@ast

A2A adenosine receptor protects tumors from antitumor T cells.

@en

type

label

A2A adenosine receptor protects tumors from antitumor T cells.

@ast

A2A adenosine receptor protects tumors from antitumor T cells.

@en

prefLabel

A2A adenosine receptor protects tumors from antitumor T cells.

@ast

A2A adenosine receptor protects tumors from antitumor T cells.

@en

P1433

Q35016529-12E09A61-1C2B-48EF-B16A-E195AEAC930C

P1476

Q35016529-0C5F228E-1FF9-4549-9B19-6761C932FBAA

P2093

Q35016529-2911436E-0788-42CD-80FB-F3AAE4A0D6CC

Q35016529-2DB56203-B13E-4FFE-ACF0-47A8954A0E89

Q35016529-448D2058-123C-47D9-A423-AAB8A470D316

Q35016529-45E2673E-9DAD-41E5-BB9B-0394487219C3

Q35016529-4BD73724-1BCD-4120-A6CD-C38720062F52

Q35016529-5BC659AD-61E8-4690-A977-A7136C7D99FF

Q35016529-63BEDAC6-5451-4311-A927-1812DF433B61

Q35016529-77EC49A4-5690-4D14-B42F-CB6B69A1A36B

Q35016529-849AC373-7FAC-4078-B5EE-A45A8BE1CAF7

Q35016529-A73DF72C-2D5F-47CE-AF06-34740CA77D50

P2860

Q35016529-01C116E0-D2B1-490C-A9BA-37AB3541CAAB

Q35016529-10B35051-0952-414F-B0E2-A24E03B9CE81

Q35016529-18F8162F-FAA1-4465-B976-67B001D7582F

Q35016529-19149DCC-E960-41CB-A8B2-FDCB73E79645

Q35016529-1A2C1989-EFDB-4A18-8C3E-03DBB185B33B

Q35016529-2F3AD37F-B0E0-47EC-873E-CB3B48D9117B

Q35016529-2FE2297F-4933-4087-9D25-9C7DEBAB13B8

Q35016529-31806EFC-BA2F-4C36-952D-8ECC2EC8D9F8

Q35016529-3D7EDA6C-4A4D-46FB-9397-108B566E97FE

Q35016529-434D24C9-1B4B-4E37-B4C5-1044B4844671

P304

Q35016529-CD3A3E38-33ED-47D8-B8C5-9C7C4BC8E341

P31

Q35016529-B836B895-FDA8-47AC-9BC7-18C7E38AFA55

P356

Q35016529-F841138E-3A0E-4A09-823B-3DE8C38E3310

P407

Q35016529-2A32DAEE-2F85-4E1A-8E04-3B851498EAE4

P433

Q35016529-21907BC7-E6DB-46BC-9EEA-6F74AA7C576B

P478

Q35016529-3CA0E365-D0ED-4303-BB34-6AF9B7F4B91E

P50

Q35016529-169AE12A-8F25-405D-B703-A4C2F8CCA47C

P577

Q35016529-996DF0E0-080D-4D08-94E9-2716FFCE4127

P5875

Q35016529-CA28458B-2D25-47ED-8352-BC6730A83C52

P698

Q35016529-18349D7F-E66E-4EF8-A389-E772A0E220F4

P932

Q35016529-3C309294-44D5-4D1A-B49A-E7497F1E7ED5

P356

PNAS.0605251103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

A2A adenosine receptor protects tumors from antitumor T cells

@en

P2093

Akio Ohta

http://www.w3.org/2001/XMLSchema#string

Dmitriy Lukashev

http://www.w3.org/2001/XMLSchema#string

Edwin K Jackson

http://www.w3.org/2001/XMLSchema#string

Elieser Gorelik

http://www.w3.org/2001/XMLSchema#string

Franca Ronchese

http://www.w3.org/2001/XMLSchema#string

Jiang-Fan Chen

http://www.w3.org/2001/XMLSchema#string

Michael K K Wong

http://www.w3.org/2001/XMLSchema#string

Michail Sitkovsky

http://www.w3.org/2001/XMLSchema#string

Patrick Smith

http://www.w3.org/2001/XMLSchema#string

Scott Abrams

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors

Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage

Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors.

Gene dose effect reveals no Gs-coupled A2A adenosine receptor reserve in murine T-lymphocytes: studies of cells from A2A-receptor-gene-deficient mice

Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion

Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice

Hypoxia--a key regulatory factor in tumour growth

IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity

P304

13132-13137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0605251103

http://www.w3.org/2001/XMLSchema#string

P407

P433

35

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P50

P577

2006-08-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6871026

http://www.w3.org/2001/XMLSchema#string

P698

16916931

http://www.w3.org/2001/XMLSchema#string

P932

1559765

http://www.w3.org/2001/XMLSchema#string